News

Castle Biosciences (NASDAQ:CSTL) has partnered with SciBase Holding AB to develop a diagnostic test aimed at forecasting ...
Initial Development Project Targets Predicting Flares in Patients Diagnosed with Atopic DermatitisFRIENDSWOOD, Texas, June 16 ...
Explore how health equity and policy shape outcomes, revealing disparities in kidney disease, atopic dermatitis, and cancer care for vulnerable populations.
Dog exposure was linked to significant changes in some genetic factors associated with risk for atopic eczema.
EMA’s veterinary medicinal products committee recommends marketing authorization to Elanco’s Zenrelia to treat atopic dermatitis in dogs: Greenfield, Indiana Monday, June 16, ...
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On ...
On June 9, Regeneron Pharmaceuticals and Sanofi (NASDAQ:SNY) announced promising interim results from the open-label Phase 4 ...
Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...
Ilunocitinib tablets are currently available in Brazil, Canada and Japan, in addition to the US. Elanco noted that, once the ...
Greater disease control and satisfaction as well as lower recurrence rates were associated with isotretinoin 20 mg vs 10 mg for seborrheic dermatitis.
A Google search on “diet and eczema” may be more misleading than helpful, warns pediatric dermatologist Sandipan Dhar.
If there is any truth to the nursery rhyme “April showers bring May flowers,” you can get ready for allergy season and eczema ...